rs150430628

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP6BS1BS2

The NM_000252.3(MTM1):​c.1052A>G​(p.Lys351Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000392 in 1,192,902 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 152 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., 7 hem., cov: 24)
Exomes 𝑓: 0.00041 ( 0 hom. 145 hem. )

Consequence

MTM1
NM_000252.3 missense, splice_region

Scores

4
6
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3

Conservation

PhyloP100: 9.24

Publications

0 publications found
Variant links:
Genes affected
MTM1 (HGNC:7448): (myotubularin 1) This gene encodes a dual-specificity phosphatase that acts on both phosphotyrosine and phosphoserine. It is required for muscle cell differentiation and mutations in this gene have been identified as being responsible for X-linked myotubular myopathy. [provided by RefSeq, Jul 2008]
MTM1 Gene-Disease associations (from GenCC):
  • X-linked myotubular myopathy
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.747
BP6
Variant X-150649900-A-G is Benign according to our data. Variant chrX-150649900-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 500885.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000196 (22/112354) while in subpopulation NFE AF = 0.000338 (18/53276). AF 95% confidence interval is 0.000218. There are 0 homozygotes in GnomAd4. There are 7 alleles in the male GnomAd4 subpopulation. Median coverage is 24. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 7 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTM1NM_000252.3 linkc.1052A>G p.Lys351Arg missense_variant, splice_region_variant Exon 10 of 15 ENST00000370396.7 NP_000243.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTM1ENST00000370396.7 linkc.1052A>G p.Lys351Arg missense_variant, splice_region_variant Exon 10 of 15 1 NM_000252.3 ENSP00000359423.3

Frequencies

GnomAD3 genomes
AF:
0.000196
AC:
22
AN:
112354
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0000323
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000188
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.000668
GnomAD2 exomes
AF:
0.000199
AC:
35
AN:
175656
AF XY:
0.000163
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000778
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000401
Gnomad OTH exome
AF:
0.000233
GnomAD4 exome
AF:
0.000413
AC:
446
AN:
1080548
Hom.:
0
Cov.:
27
AF XY:
0.000418
AC XY:
145
AN XY:
347190
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26030
American (AMR)
AF:
0.000117
AC:
4
AN:
34293
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19140
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29989
South Asian (SAS)
AF:
0.00
AC:
0
AN:
51934
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40431
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4005
European-Non Finnish (NFE)
AF:
0.000523
AC:
434
AN:
829255
Other (OTH)
AF:
0.000154
AC:
7
AN:
45471
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000196
AC:
22
AN:
112354
Hom.:
0
Cov.:
24
AF XY:
0.000203
AC XY:
7
AN XY:
34500
show subpopulations
African (AFR)
AF:
0.0000323
AC:
1
AN:
30929
American (AMR)
AF:
0.000188
AC:
2
AN:
10628
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2659
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3615
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2730
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6097
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000338
AC:
18
AN:
53276
Other (OTH)
AF:
0.000668
AC:
1
AN:
1496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000433
Hom.:
3
Bravo
AF:
0.000215
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000298
AC:
2
ExAC
AF:
0.000140
AC:
17

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Apr 22, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 20, 2020
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 06, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Severe X-linked myotubular myopathy Benign:2
Jan 06, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Jan 03, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1052A>G (p.K351R) alteration is located in exon 10 (coding exon 9) of the MTM1 gene. This alteration results from a A to G substitution at nucleotide position 1052, causing the lysine (K) at amino acid position 351 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Uncertain
0.063
T
BayesDel_noAF
Pathogenic
0.17
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.74
D
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Benign
0.80
T
M_CAP
Pathogenic
0.49
D
MetaRNN
Pathogenic
0.75
D
MetaSVM
Uncertain
-0.15
T
MutationAssessor
Benign
0.57
N
PhyloP100
9.2
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-1.7
N
REVEL
Uncertain
0.43
Sift
Benign
0.42
T
Sift4G
Benign
0.47
T
Polyphen
0.019
B
Vest4
0.77
MVP
0.99
MPC
1.5
ClinPred
0.19
T
GERP RS
5.7
Varity_R
0.54
gMVP
0.70
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150430628; hg19: chrX-149818373; API